分子診斷市場：按產品類型、應用、最終用戶和地區分類

Molecular Diagnostics Market, By Product Type, By Application, By End-User, By Geography

出版日期: 2026年04月01日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，分子診斷市場規模將達到206.7億美元，到2033年將達到474.4億美元。預計從2026年到2033年，該市場將以12.6%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	206.7億美元
歷史數據時期：	2020-2024	預測期：	2026-2033
2026年至2033年預測期間的複合年成長率：	12.60%	2033年市場規模預測：	474.4億美元

分子診斷是一個不斷發展的領域，它在分子層面上分析生物標記，用於疾病檢測、風險預測或新治療方法的開發。分子診斷已成為現代醫學的基本工具，幫助臨床醫生檢測和監測疾病，並制定治療策略。 DNA定序和聚合酵素鏈鎖反應（PCR）等技術檢測生物標記的能力徹底改變了醫學檢測方式，並顯著改善了患者的治療效果。分子診斷技術的進步，以及基因定序成本的降低，正在推動其在包括傳染病檢查、腫瘤學和個人化醫療在內的各個應用領域的普及。持續的研發活動正在進一步拓展分析能力，預計這將有助於市場的持續成長。

市場動態

受多種因素驅動，全球分子診斷市場正經歷強勁成長。慢性病和感染疾病在全球範圍內的日益流行，推動了對先進診斷技術的需求。與傳統方法相比，分子診斷測試能夠更早、更準確地檢測疾病。個人化醫療和伴隨診斷需求的成長是另一個主要促進因素，因為分子檢測有助於為個別患者確定最有效的治療方法。高效能篩檢、自動化工作流程和分散式檢查環境等技術的進步，正在拓展分子診斷的應用範圍。然而，高成本和熟練人員的短缺限制著市場成長。定序成本的持續下降，以及攜帶式和方便用戶使用型設備的開發，正在為新的應用領域，特別是分散式和照護現場（PoC）環境，開闢新的機會。

本研究的關鍵特徵

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對全球分子診斷市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、機器類型升級、市場擴張和行銷策略做出明智的決策。
全球分子診斷市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過分析全球分子診斷市場中使用的各種策略矩陣輕鬆做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第8章競爭情勢

Hoffmann-La Roche Ltd
Illumina, Inc.
Hologic, Inc.
Agilent Technologies Inc.
Qiagen NV
Myriad Genetics
Becton, Dickinson and Company
Abbott Laboratories
bioMerieux SA
Bio-Rad Laboratories, Inc.
Sysmex Corporation
Danaher Corporation（Beckman Coulter Inc.）
Thermo Fisher Scientific Inc.
Siemens Healthineers AG
Johnson & Johnson
Alere Inc.
Cepheid
Gen-Probe Incorporated
LabCorp（Monogram Biosciences）
Novartis AG

第9章分析師建議

機會分析
一致的機會地圖

第10章：參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI1545

Molecular Diagnostics Market is estimated to be valued at USD 20.67 Bn in 2026 and is expected to reach USD 47.44 Bn by 2033, growing at a compound annual growth rate (CAGR) of 12.6% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 20.67 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	12.60%	2033 Value Projection:	USD 47.44 Bn

Molecular diagnostics is an evolving field that involves the analysis of biological markers, or biomarkers, at the molecular level to test for diseases, predict risk or identify new therapeutic options. Molecular diagnostics has become a fundamental tool in modern healthcare, helping clinicians detect and monitor disease along with making treatment decisions. The ability to detect biomarkers through techniques such as DNA sequencing and polymerase chain reaction (PCR) has revolutionized medical testing and significantly improved patient outcomes. Advances in molecular diagnostic techniques coupled with the declining costs of genetic sequencing are helping drive widespread adoption across various applications areas such as infectious disease testing, oncology and personalized medicine. Continued research and development is further expanding analytical capabilities which is expected to contribute to the ongoing expansion of the market.

Market Dynamics

The global molecular diagnostics market is witnessing strong growth driven by several factors. Rising prevalence of chronic and infectious diseases worldwide have increased the need for advanced diagnostic techniques. Molecular diagnostic tests offer earlier, more accurate detection of diseases compared to conventional methods. Growing demand for personalized medicine and companion diagnostics is another key driver as molecular tests help identify the most effective therapies for individual patients. Technological advancements enabling high-throughput screening, automated workflow processes and decentralized testing environments are expanding molecular diagnostic capabilities. However, high costs of instruments and lack of skilled labor restrain the market growth. Ongoing reductions in sequencing costs along with the development of portable, easy-to-use instruments opens opportunities in new applications areas, especially in decentralized, point-of-care settings.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global molecular diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abbott Laboratories, Becton, Dickinson and Company, Biomerieux SA, Danaher Corporation, Diasorin SPA, Hologic Inc., QIAGEN N.V., Roche Diagnostics.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global molecular diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global molecular diagnostics market.

Market Segmentation

Product Type Insights (Revenue, USD Bn, 2026 - 2033)
Reagents & Kits
Instruments
Application Insights (Revenue, USD Bn, 2026 - 2033)
Oncology
Genetic Testing
Microbiology
STDs
Blood Screening
Virology
Tissue Typing
Prenatal Diagnosis
Others
End-user Insights (Revenue, USD Bn, 2026 - 2033)
Hospitals and Diagnostic Laboratories
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs)
Point-of-Care Settings
Regional Insights (Revenue, USD Bn, 2026 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Hoffmann-La Roche Ltd
Illumina, Inc.
Hologic, Inc.
Agilent Technologies Inc.
Qiagen N.V.
Myriad Genetics
Becton, Dickinson and Company
Abbott Laboratories
bioMerieux SA
Bio-Rad Laboratories, Inc.
Sysmex Corporation
Danaher Corporation (Beckman Coulter Inc.)
Thermo Fisher Scientific Inc.
Siemens Healthineers AG
Johnson & Johnson
Alere Inc.
Cepheid
Gen-Probe Incorporated
LabCorp (Monogram Biosciences)
Novartis AG

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Molecular Diagnostics Market, By Product Type
- Global Molecular Diagnostics Market, By Application
- Global Molecular Diagnostics Market, By End-User
- Global Molecular Diagnostics Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Molecular Diagnostics Market, By Product Type, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Reagents & Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)

5. Global Molecular Diagnostics Market, By Application, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
Genetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
Microbiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
STDs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
Blood Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
Virology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
Tissue Typing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
Prenatal Diagnosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)

6. Global Molecular Diagnostics Market, By End-User, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Hospitals and Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
Point-of-Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)

7. Global Molecular Diagnostics Market, By Region, 2026 - 2033, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2026,2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2026 - 2033, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End-User , 2021 - 2033, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End-User , 2021 - 2033, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End-User , 2021 - 2033, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End-User , 2021 - 2033, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End-User , 2021 - 2033, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End-User , 2021 - 2033, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hologic, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent Technologies Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Qiagen N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Myriad Genetics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
bioMerieux SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sysmex Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Danaher Corporation (Beckman Coulter Inc.)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Siemens Healthineers AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Alere Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cepheid
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Gen-Probe Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
LabCorp (Monogram Biosciences)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies